News

What Are Peptides? Understanding the Building Blocks of Repair

DATE PUBLISHED

Peptides are short chains of amino acids—the same compounds that make up proteins. Your body naturally produces peptides every day, and they help act as messengers that support communication between cells, tissues, and organs. 

These signaling compounds are involved in normal biological signaling processes studies across metabolism, immune activity and cellular communication. As we age—or when stress, poor nutrition, environmental toxins, or inflammation increase—natural peptide production may become less efficient. 

What is BPC?

BPC (Body Protection Compound) refers to a peptide originally identified in gastric juices and studied for its potential role in supporting healthy inflammatory balance, tissue function, and overall cellular resilience.  
BPC has gained attention for its potential influence on:

BPC is often discussed in wellness and functional medicine circles for its potential in supporting the body’s natural recovery processes. 

What is BPC Used For?

BPC is most often studied for its potential role in supporting general wellness and active lifestyle routines.  

Gut Health Support

Because BPC was originally identified in gastric compounds, much of the early research has focused on digestive health. Preclinical studies suggest it may help support gut tissue integrity and balanced inflammatory responses during periods of digestive stress. 

Musculoskeletal Recovery

BPC has also been studied for its potential role in supporting tendon, ligament, and muscle health. Animal and lab studies suggest it may influence collagen production, and healthy tissue function —making it of interest for active individuals focused on recovery, mobility, and overall wellness. 

Vascular and Circulatory Health

Healthy circulation plays an important role in overall tissue function and recovery. Early research suggests BPC may support vascular function by supporting nitric oxide pathways, vasodilation, and circulation. 

Neurological and Systemic Support

Emerging research is also exploring BPC’s potential role in tissue resilience throughout the body. 

While human research is still limited, these early findings are why BPC continues to attract interest in recovery-focused wellness and healthy aging discussions. 

What Are the Benefits of BPC?

The potential benefits of BPC center around one theme: supporting the body’s natural recovery and resilience.
Some of the most discussed areas of support include:

  1. Gut Health and Digestive Resilience: BPC may help support a healthy gut lining and healthy inflammatory balance, which may be especially helpful during periods of digestive stress.
  2. Tendon, Ligament, and Muscle Support: BPC is often discussed in the context of musculoskeletal recovery because of its potential role in collagen formation and tissue support.  
  3. Nervous System Support: Preclinical studies suggest BPC may support neurological function and signaling.
  4. Whole-Body Wellness Potential: Researchers continue exploring how BPC may support healthy function across multiple systems—not just the gut or muscles, but broader tissue resilience throughout the body.

Research interest in peptides continues to grow within wellness and healthy aging discussions. Much of the current research remains preclinical, and more human studies are needed.

What’s the Difference Between BPC, KPV, and TB-500?

These three peptides are often discussed together because they may offer complementary support—but they work differently. 

BPC is primarily associated with gut support and musculoskeletal wellness. It is often discussed as a foundational peptide for recovery-focused wellness protocols.  

KPV is a small tripeptide made of lysine, proline, and valine. It is derived from alpha-MSH (alpha-melanocyte-stimulating hormone) and is best known for supporting healthy inflammatory responses. Like BPC, KPV is often discussed for gut health and immune balance. 
TB-500 is derived from thymosin beta-4, a naturally occurring peptide involved in cellular function and tissue support. It is commonly associated with vascular support, healthy tissue function, and recovery after physical stress or training demands. 

What is the Wolverine Stack?

In wellness communities, you may hear people talk about the “Wolverine Stack.”

This nickname commonly refers to pairing BPC with TB-500, with KPV sometimes included, depending on individual wellness goals. The name comes from the idea of supporting recovery and resilience, like the comic book character known for rapid recovery. 

These peptides are often discussed together because they may offer complementary support:

  • BPC is commonly explored for gut support, healthy inflammatory balance, and musculoskeletal wellness
  • TB-500 is often associated with tissue support, mobility, and recovery after physical stress

KPV is typically discussed for its potential role in supporting healthy inflammatory responses and gut resilience

Rather than focusing on a single area, this combination is often mentioned in wellness circles for broader support during periods of physical stress, training demands, or recovery-focused routines. 

It’s essential to note that research on these peptides is still in its early stages, and much of the available evidence is derived from preclinical studies. More human research is needed to better understand how these peptides function individually and in combination, as well as their long-term safety and efficacy. 

Are There Any Side Effects to BPC?

Because BPC is still considered a research-focused compound, human safety data remains limited. 

Animal studies have not identified significant safety concerns to date. However, this does not replace well-designed human studies. 

Potential considerations:

  • Individual tolerance may vary
  • Quality and sourcing matter significantly
  • Product quality and formulation standards may vary
  • It should always be discussed with a qualified healthcare provider

The Future of Peptides

Peptides are becoming a major conversation in modern health. BPC is one example receiving growing interest in wellness and healthy aging discussions. While the science is still evolving, the growing interest in recovery-focused wellness and healthy aging suggests peptides may continue shaping the future of personalized health support. 

The goal isn’t simply to live longer—it’s to support how well we live. And that’s where peptides like BPC may offer meaningful potential. 

 

Disclaimer: BPC is primarily studied in preclinical settings, and more human research is needed to fully understand its safety, effectiveness, and long-term use. Always discuss supplements with your healthcare provider.

Share Article

NEXT UP:

Hormones
Keep reading
Detox
Keep reading

Reference

Bhullar, K. S., &
Wu, J. (2020). Dietary peptides in aging: Evidence and prospects. Food Science and Human
Wellness, 9(1), 1–7. https://doi.org/10.1016/j.fshw.2020.01.001

Bock-Marquette, I., Saxena, A., White, M. D.,
Dimaio, J. M., & Srivastava, D. (2004). Thymosin beta4 activates
integrin-linked kinase and promotes cardiac cell migration, survival and
cardiac repair. Nature, 432(7016), 466–472. https://doi.org/10.1038/nature03000

Chang, C. H., Tsai, W. C., Hsu, Y. H., &
Pang, J. H. (2014). Pentadecapeptide BPC 157 enhances the growth hormone
receptor expression in tendon fibroblasts. Molecules
(Basel, Switzerland), 19(11), 19066–19077. https://doi.org/10.3390/molecules191119066

Dalmasso, G., Charrier-Hisamuddin, L., Nguyen,
H. T., Yan, Y., Sitaraman, S., & Merlin, D. (2008). PepT1-mediated
tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166–178. https://doi.org/10.1053/j.gastro.2007.10.026

Deek S. A. (2021). BPC 157 as Potential
Treatment for COVID-19. Medical
hypotheses, 158, 110736. Advance online publication. https://doi.org/10.1016/j.mehy.2021.110736

Duzel, A., Vlainic, J., Antunovic, M.,
Malekinusic, D., Vrdoljak, B., Samara, M., Gojkovic, S., Krezic, I., Vidovic,
T., Bilic, Z., Knezevic, M., Sever, M., Lojo, N., Kokot, A., Kolovrat, M.,
Drmic, D., Vukojevic, J., Kralj, T., Kasnik, K., Siroglavic, M., … Sikiric, P.
(2017). Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and
ischemia and reperfusion in rats: New insights. World journal of
gastroenterology, 23(48), 8465–8488. https://doi.org/10.3748/wjg.v23.i48.8465

Ehrlich, H. P., & Hazard, S. W., 3rd
(2010). Thymosin beta4 enhances repair by organizing connective tissue and
preventing the appearance of myofibroblasts. Annals of the
New York Academy of Sciences, 1194, 118–124. https://doi.org/10.1111/j.1749-6632.2010.05483.x

Getting, S. J., Schiöth, H. B., & Perretti,
M. (2003). Dissection of the anti-inflammatory effect of the core and
C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. The Journal of
pharmacology and experimental therapeutics, 306(2), 631–637. https://doi.org/10.1124/jpet.103.051623

Goldstein, A. L., Hannappel, E., &
Kleinman, H. K. (2005). Thymosin beta4: actin-sequestering protein moonlights
to repair injured tissues. Trends in
molecular medicine, 11(9), 421–429. https://doi.org/10.1016/j.molmed.2005.07.004

Gwyer, D., Wragg, N. M., & Wilson, S. L.
(2019). Gastric pentadecapeptide body protection compound BPC 157 and its role
in accelerating musculoskeletal soft tissue healing. Cell and tissue research, 377(2), 153–159. https://doi.org/10.1007/s00441-019-03016-8

Hsieh, M. J., Lee, C.
H., Chueh, H. Y., Lin, Y. H., Lin, W. C., Chen, C. H., & Hsieh, I. C.
(2020). Modulatory effects of BPC 157 on vasomotor tone and the activation of
Src-Caveolin-1-endothelial nitric oxide synthase pathway. Scientific Reports, 10, 17078. https://doi.org/10.1038/s41598-020-74022-y

Józwiak,
M., Bauer, M., Kamysz, W., & Kleczkowska, P. (2025). Multifunctionality and
Possible Medical Application of the BPC 157 Peptide—Literature and Patent
Review. Pharmaceuticals, 18(2), 185.
https://doi.org/10.3390/ph18020185

Land S. C. (2012). Inhibition of cellular and
systemic inflammation cues in human bronchial epithelial cells by
melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. International journal of
physiology, pathophysiology and pharmacology, 4(2), 59–73.

Lau, J. L., & Dunn, M. K. (2018).
Therapeutic peptides: Historical perspectives, current development trends, and
future directions. Bioorganic
& medicinal chemistry, 26(10), 2700–2707. https://doi.org/10.1016/j.bmc.2017.06.052

Luger, T. A., & Brzoska, T. (2007).
alpha-MSH related peptides: a new class of anti-inflammatory and
immunomodulating drugs. Annals of the
rheumatic diseases, 66 Suppl 3(Suppl
3), iii52–iii55. https://doi.org/10.1136/ard.2007.079780

Luo, Y., Zhang, Y., Xiong, Z., Chen, X., Sha,
A., Xiao, W., Peng, L., Zou, L., Han, J., & Li, Q. (2024). Peptides Used
for Heavy Metal Remediation: A Promising Approach. International journal of
molecular sciences, 25(12),
6717. https://doi.org/10.3390/ijms25126717

Perovic, D., Milavic, M., Dokuzovic, S.,
Krezic, I., Gojkovic, S., Vranes, H., Bebek, I., Bilic, V., Somun, N., Brizic,
I., Skorak, I., Hriberski, K., Sikiric, S., Lovric, E., Strbe, S., Kubat, M.,
Boban Blagaic, A., Skrtic, A., Seiwerth, S., & Sikiric, P. (2022). Novel
Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and
Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157
Therapy. Current issues
in molecular biology, 44(5),
1901–1927. https://doi.org/10.3390/cimb44050130

Quiroz, C., Saavedra, Y. B., Armijo-Galdames,
B., Amado-Hinojosa, J., Olivera-Nappa, Á., Sanchez-Daza, A., &
Medina-Ortiz, D. (2021). Peptipedia: a user-friendly web application and a
comprehensive database for peptide research supported by Machine Learning
approach. Database : the
journal of biological databases and curation, 2021,
baab055. https://doi.org/10.1093/database/baab055

Seiwerth, S., Brcic, L., Vuletic, L. B.,
Kolenc, D., Aralica, G., Misic, M., Zenko, A., Drmic, D., Rucman, R., &
Sikiric, P. (2014). BPC 157 and blood vessels. Current pharmaceutical
design, 20(7), 1121–1125. https://doi.org/10.2174/13816128113199990421

Seiwerth, S., Rucman, R., Turkovic, B., Sever,
M., Klicek, R., Radic, B., Drmic, D., Stupnisek, M., Misic, M., Vuletic, L. B.,
Pavlov, K. H., Barisic, I., Kokot, A., Japjec, M., Blagaic, A. B., Tvrdeic, A.,
Rokotov, D. S., Vrcic, H., Staresinic, M., Sebecic, B., … Sikiric, P. (2018).
BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing,
Lessons from Tendon, Ligament, Muscle and Bone Healing. Current pharmaceutical
design, 24(18), 1972–1989. https://doi.org/10.2174/1381612824666180712110447

Seiwerth, S., Milavic, M., Vukojevic, J.,
Gojkovic, S., Krezic, I., Vuletic, L. B., Pavlov, K. H., Petrovic, A., Sikiric,
S., Vranes, H., Prtoric, A., Zizek, H., Durasin, T., Dobric, I., Staresinic,
M., Strbe, S., Knezevic, M., Sola, M., Kokot, A., Sever, M., … Sikiric, P.
(2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in pharmacology, 12, 627533. https://doi.org/10.3389/fphar.2021.627533

Sikirić, P., Petek, M., Rucman, R., Seiwerth,
S., Grabarević, Z., Rotkvić, I., Turković, B., Jagić, V., Mildner, B., &
Duvnjak, M. (1993). A new gastric juice peptide, BPC. An overview of the
stomach-stress-organoprotection hypothesis and beneficial effects of BPC. Journal of physiology,
Paris, 87(5), 313–327. https://doi.org/10.1016/0928-4257(93)90038-u

Sikirić, P., Seiwerth, S., Grabarević, Z.,
Rucman, R., Petek, M., Jagić, V., Turković, B., Rotkvić, I., Mise, S., Zoricić,
I., Gjurasin, M., Konjevoda, P., Separović, J., Ljubanović, D., Artuković, B.,
Bratulić, M., Tisljar, M., Jurina, L., Buljat, G., Miklić, P., … Marović, A.
(1996). Beneficial effect of a novel pentadecapeptide BPC 157 on gastric
lesions induced by restraint stress, ethanol, indomethacin, and capsaicin
neurotoxicity. Digestive
diseases and sciences, 41(8), 1604–1614. https://doi.org/10.1007/BF02087908

Sikiric, P., Seiwerth, S., Rucman, R.,
Turkovic, B., Rokotov, D. S., Brcic, L., Sever, M., Klicek, R., Radic, B.,
Drmic, D., Ilic, S., Kolenc, D., Vrcic, H., & Sebecic, B. (2011). Stable
gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Current pharmaceutical
design, 17(16), 1612–1632. https://doi.org/10.2174/138161211796196954

Sikiric, P., Seiwerth, S., Rucman, R.,
Turkovic, B., Rokotov, D. S., Brcic, L., Sever, M., Klicek, R., Radic, B.,
Drmic, D., Ilic, S., Kolenc, D., Stambolija, V., Zoricic, Z., Vrcic, H., &
Sebecic, B. (2012). Focus on ulcerative colitis: stable gastric
pentadecapeptide BPC 157. Current medicinal chemistry, 19(1),
126–132. https://doi.org/10.2174/092986712803414015

Sikiric, P., Seiwerth, S., Rucman, R., Kolenc,
D., Vuletic, L. B., Drmic, D., Grgic, T., Strbe, S., Zukanovic, G., Crvenkovic,
D., Madzarac, G., Rukavina, I., Sucic, M., Baric, M., Starcevic, N.,
Krstonijevic, Z., Bencic, M. L., Filipcic, I., Rokotov, D. S., & Vlainic,
J. (2016). Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and
Practical Implications. Current
neuropharmacology, 14(8),
857–865. https://doi.org/10.2174/1570159x13666160502153022

Sikiric, P., Seiwerth, S., Rucman, R., Drmic,
D., Stupnisek, M., Kokot, A., Sever, M., Zoricic, I., Zoricic, Z., Batelja, L.,
Ziger, T., Luetic, K., Vlainic, J., Rasic, Z., & Bencic, M. L. (2017).
Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157.
Finally, do we have a Solution?. Current
pharmaceutical design, 23(27), 4012–4028. https://doi.org/10.2174/1381612823666170220163219

Sikiric, P., Rucman, R., Turkovic, B., Sever,
M., Klicek, R., Radic, B., Drmic, D., Stupnisek, M., Misic, M., Vuletic, L. B.,
Pavlov, K. H., Barisic, I., Kokot, A., Peklic, M., Strbe, S., Blagaic, A. B.,
Tvrdeic, A., Rokotov, D. S., Vrcic, H., Staresinic, M., … Seiwerth, S. (2018).
Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157.
Vascular Recruitment and Gastrointestinal Tract Healing. Current pharmaceutical
design, 24(18), 1990–2001. https://doi.org/10.2174/1381612824666180608101119

Sikiric, P., Hahm, K. B., Blagaic, A. B.,
Tvrdeic, A., Pavlov, K. H., Petrovic, A., Kokot, A., Gojkovic, S., Krezic, I.,
Drmic, D., Rucman, R., & Seiwerth, S. (2020). Stable Gastric
Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive
Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress,
Achievements, and the Future. Gut and liver, 14(2),
153–167. https://doi.org/10.5009/gnl18490

Sikiric, P., Drmic, D., Sever, M., Klicek, R.,
Blagaic, A. B., Tvrdeic, A., Kralj, T., Kovac, K. K., Vukojevic, J.,
Siroglavic, M., Gojkovic, S., Krezic, I., Pavlov, K. H., Rasic, D., Mirkovic,
I., Kokot, A., Skrtic, A., & Seiwerth, S. (2020). Fistulas Healing. Stable
Gastric Pentadecapeptide BPC 157 Therapy. Current
pharmaceutical design, 26(25), 2991–3000. https://doi.org/10.2174/1381612826666200424180139

Sikiric, P., Gojkovic, S., Krezic, I., Smoday,
I. M., Kalogjera, L., Zizek, H., Oroz, K., Vranes, H., Vukovic, V., Labidi, M.,
Strbe, S., Baketic Oreskovic, L., Sever, M., Tepes, M., Knezevic, M., Barisic,
I., Blagaic, V., Vlainic, J., Dobric, I., Staresinic, M., … Seiwerth, S.
(2023). Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and
Gut-Brain Axis Function. Pharmaceuticals
(Basel, Switzerland), 16(5),
676. https://doi.org/10.3390/ph16050676

Vasireddi, N., Hahamyan, H., Salata, M. J., Karns,
M., Calcei, J. G., Voos, J. E., & Apostolakos, J. M. (2025). Emerging Use
of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS journal : the
musculoskeletal journal of Hospital for Special Surgery, 21(4), 15563316251355551. Advance online publication. https://doi.org/10.1177/15563316251355551

Vukojević, J., Siroglavić, M., Kašnik, K.,
Kralj, T., Stanćić, D., Kokot, A., Kolarić, D., Drmić, D., Sever, A. Z.,
Barišić, I., Šuran, J., Bojić, D., Patrlj, M. H., Sjekavica, I., Pavlov, K. H.,
Vidović, T., Vlainić, J., Stupnišek, M., Seiwerth, S., & Sikirić, P.
(2018). Rat inferior caval vein (ICV) ligature and particular new insights with
the stable gastric pentadecapeptide BPC 157. Vascular
pharmacology, 106, 54–66. https://doi.org/10.1016/j.vph.2018.02.010

Vukojević, J., Vrdoljak, B., Malekinušić, D.,
Siroglavić, M., Milavić, M., Kolenc, D., Boban Blagaić, A., Batelja, L., Drmić,
D., Seiverth, S., & Sikirić, P. (2020). The effect of pentadecapeptide BPC
157 on hippocampal ischemia/reperfusion injuries in rats. Brain and behavior, 10(8), e01726. https://doi.org/10.1002/brb3.1726

Vukojevic, J., Milavić, M., Perović, D., Ilić,
S., Čilić, A. Z., Đuran, N., Štrbe, S., Zoričić, Z., Filipčić, I., Brečić, P.,
Seiverth, S., & Sikirić, P. (2022). Pentadecapeptide BPC 157 and the
central nervous system. Neural
regeneration research, 17(3),
482–487. https://doi.org/10.4103/1673-5374.320969

Whitehouse M. (2025). Concerning BPC-157, a
natural pentadecapeptide, that acts as a cytoprotectant and is believed to
protect the gastro-intestinal tract (GIT). Inflammopharmacology, 33(8), 4879–4881. https://doi.org/10.1007/s10787-025-01882-z

Xing, Y., Ye, Y., Zuo, H., & Li, Y. (2021).
Progress on the Function and Application of Thymosin β4. Frontiers in endocrinology, 12,
767785. https://doi.org/10.3389/fendo.2021.767785

Zakir, S. K., Jawed, B., Esposito, J. E.,
Kanwal, R., Pulcini, R., Martinotti, R., Ceci, E., Botteghi, M., Gaudio, F.,
Toniato, E., & Martinotti, S. (2025). The Role of Peptides in Nutrition:
Insights into Metabolic, Musculoskeletal, and Behavioral Health: A Systematic
Review. International
journal of molecular sciences, 26(13),
6043. https://doi.org/10.3390/ijms26136043